Prof. Dr. Heribert Schunkert
Academic Career and Research Areas
Prof. Dr. med. Heribert Schunkert has been Professor of Cardiology at the Technical University of Munich and Director of the Department of Cardiology at the German Heart Center since 2012. From 1988 to 1991, he completed a DFG research fellowship at Brigham and Women's Hospital in Boston, USA. He completed his clinical training at the University Hospitals of Aachen and Regensburg, as well as at Beth Israel Hospital and Massachusetts General Hospital in Boston, USA, before becoming a professor in Regensburg. From 2002 to 2012, Prof. Schunkert was Director of Internal Medicine and Cardiology at the University of Lübeck.
He conducts research into the molecular genetics of multifactorial cardiovascular diseases and has coordinated several EU and BMBF-funded projects as well as a European-American Leducq network to identify the genetic roots of myocardial infarction. He is the author of more than 700 publications in international journals with an h-index > 124.
Awards
- Franz-Loogen-Preis der Deutschen Gesellschaft für Kardiologie (2019)
- Geoffrey-Rose-Lecture, European Society of Cardiology (2022)
- Bayerischer Verdienstorden (2023)
Key Publications
Schunkert H, et al. Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease. Eur Heart J. 2025 Feb 5:ehae649.
AbstractTrastulla L, …, Müller-Myhsok B, Schunkert H, Ziller MJ. Distinct genetic liability profiles define clinically relevant patient strata across common diseases. Nat Commun. 2024;15:5534.
AbstractLi L, Pang S, Starnecker F, Mueller-Myhsok B, Schunkert H. Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease. Eur Heart J. 2024;45:1843-1852.
AbstractSharifi MA, …, , Mann M, Schunkert H, Kessler T. ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1. Circ Res. 2023;133:674-686.
AbstractMauersberger C, Sager HB, …, Schunkert H, Kessler T. Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation. Nat Cardiovasc Res. 2022 Dec;1(12):1174-1186.
AbstractIf you wish your profile to be changed or updated please contact Franz Langer.